Optease Vena Cava Filter and Optease Retrieval Cathteter
by Cordis, A Johnson & Johnson Co.
510(k) K140286
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK140286 | Date7 Mar 2014 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTK
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.3375
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The OptEase Vena Cava Filter and Retrieval Catheter is an intravascular filter designed for placement within the inferior vena cava to prevent pulmonary embolism by capturing venous thrombi. It is classified as a retrievable device, allowing for removal once the risk of embolism has resolved, typically within up to 12 days post-implantation. The filter is engineered to minimize complications associated with long-term placement while providing temporary protection for patients at risk of deep vein thrombosis.
This device is supplied as a kit, including a 90 cm catheter for delivery through multiple venous access sites, such as the femoral, jugular, or antecubital veins. It is intended for single-use and requires sterile handling in a clinical setting, such as a catheterization lab or operating room. The OptEase system has received FDA 510(k) clearance under the Special 510(k) pathway, adhering to regulatory standards for cardiovascular devices classified under DTK (Device Type Code). No additional regulatory markings or MRI safety classifications are specified.
Other devices from Cordis Corp., A Johnson & Johnson Co.
See all devices from Cordis Corp., A Johnson & Johnson Co. →
Questions
AI-generated answers, 1 Oct 2026
What is the OptEase Vena Cava Filter designed to do?
The OptEase Vena Cava Filter is an intravascular device placed within the inferior vena cava to prevent pulmonary embolism by trapping venous thrombi. It is specifically engineered as a retrievable filter, allowing for removal once the patient’s risk of embolism has resolved, typically within up to 12 days after implantation. This design minimizes complications associated with long-term placement while providing temporary protection for patients at risk of deep vein thrombosis.
How is the OptEase Vena Cava Filter supplied, and what access sites can it use?
The OptEase Vena Cava Filter is supplied as a complete kit, including a 90 cm catheter. This catheter is designed for delivery through multiple venous access sites, such as the femoral, jugular, or antecubital veins. The kit ensures all necessary components are available for immediate use in a clinical setting like a catheterization lab or operating room.
Is the OptEase Vena Cava Filter intended for single-use or reuse?
The OptEase Vena Cava Filter is intended for single-use only. This design ensures sterility and safety, as it requires sterile handling in a controlled clinical environment. Reuse is not recommended or supported by the manufacturer to maintain efficacy and prevent contamination.
What are the key considerations for storage of the OptEase Vena Cava Filter kit?
The OptEase Vena Cava Filter kit must be stored in a manner that preserves its sterility and integrity. It should be kept in its original packaging, protected from moisture, dust, and extreme temperatures. The manufacturer’s instructions for storage conditions should be followed to ensure the device remains functional and safe for use when needed.
What regulatory pathway does the OptEase Vena Cava Filter follow?
The OptEase Vena Cava Filter has received FDA 510(k) clearance under the Special 510(k) pathway. This pathway is used for devices that are substantially equivalent to a predicate device already on the market. The clearance was granted by the FDA’s Cardiovascular (CV) advisory committee, adhering to regulatory standards for cardiovascular devices classified under Device Type Code (DTK).